Your Intimate Health Deserves the Same Clinical Excellence as the Rest of You.

Completely. Your records are held with the same legal protections as any medical record under HIPAA. The consultation, the treatment, and the follow-up are private. No employer, no family member, and no insurer receives this information without your explicit written consent. Many of Arbour Longevity's sexual wellness patients are professionals, executives, and public figures who cannot have this information disclosed. It never is.

PDE5 inhibitors like Viagra and Cialis temporarily increase blood flow to the penis by inhibiting the enzyme that degrades cGMP. They work acutely but do nothing to address the underlying endothelial dysfunction, neurological deficit, or vascular compromise that causes ED in the first place. The P-Shot delivers concentrated platelet-derived growth factors — VEGF, PDGF, and TGF-β — directly into erectile tissue. This stimulates new blood vessel formation, nerve regeneration, and tissue remodeling. The goal is restoration of physiological function, not temporary pharmacological augmentation. LiSWT amplifies this by mechanically stimulating new blood vessel growth. The combination produces durable improvement, not a pill you need to take before every encounter.

The honest answer: the evidence for the O-Shot is promising but still emerging. A 2023 systematic review concluded the evidence base needs more randomized controlled trials. Existing studies show meaningful improvements in lubrication, arousal, orgasmic function, and stress urinary incontinence. These include a Brazil pilot study of 68 women, where 94% reported satisfaction, and other published case series. A 2021 study reported orgasm scores more than doubled after treatment. At Arbour Longevity, the O-Shot is offered with clinical honesty about what the evidence shows. It is not presented as a guarantee. It's presented as a well-tolerated regenerative intervention with meaningful patient-reported outcomes in the existing literature. The key variable that most O-Shot providers miss is hormonal optimization. Estrogen-replete tissue responds dramatically differently to PRP than atrophied, estrogen-deficient tissue. Arbour Longevity assesses this before every O-Shot.

PT-141 (bremelanotide) is the same compound as Vyleesi, which is FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women. At Arbour Longevity, PT-141 is dispensed as a compounded peptide, which is significantly more cost-effective than the brand-name Vyleesi. Pricing is discussed at consultation. Its use in men for low libido and ED has not been reviewed or approved by the FDA. This is disclosed and discussed at consultation. PT-141 works differently from any other sexual wellness treatment: it acts on melanocortin receptors in the brain, stimulating desire neurologically rather than through blood flow. It can be used by both men and women. It takes effect in 30–45 minutes, and effects last up to 72 hours.

Both procedures use topical numbing cream applied 30–45 minutes before treatment, and a local anesthetic block for the P-Shot specifically. Most patients describe the sensation as significantly less than they expected. The blood draw is the same as any lab draw. The injection itself is brief. Post-procedure, mild soreness lasting 1–3 days is common for the P-Shot. The O-Shot typically involves minimal post-procedure discomfort. ProNox (nitrous oxide) is available for patients with significant procedural anxiety.

The outcome of your PRP treatment depends substantially on the hormonal environment of the tissue being treated. Testosterone directly influences the density and responsiveness of erectile tissue. Estrogen governs vaginal tissue thickness, receptor sensitivity, and lubrication capacity. A P-Shot delivered into testosterone-deficient tissue generates a fraction of the growth factor response of the same treatment in hormonally optimized tissue. The same is true for the O-Shot. At Arbour Longevity, this is not an upsell. It's a clinical imperative. Most sexual wellness patients benefit meaningfully from addressing the hormonal foundation before or alongside their regenerative treatments.